Biogen
+$1.98 (+0.97%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.
About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis.
CEO
Michel Vounatsos
Employees
9,610
Headquarters
Cambridge, Massachusetts
Founded
1978
BIIB Key Statistics
Market cap
30.20B
Price-Earnings ratio
21.13
Dividend yield
—
Average volume
927.80K
High today
$207.36
Low today
$203.13
Open price
$205.26
Volume
1.01M
52 Week high
$468.55
52 Week low
$187.16
BIIB News
Analyst ratings
50%
of 34 ratings
Buy
47.1%
Hold
50%
Sell
2.9%
BIIB Earnings
$0.00
$2.95
$5.89
$8.84
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, Pre-Market